Logo

PhyNexus Signs Deal for Qiagen Resin

Sep 27, 2004

NEW YORK, Sept. 27 (GenomeWeb News) - PhyNexus said today that it has signed a deal under which Qiagen has granted PhyNexus the right to incorporate Qiagen's Ni-NTA resin for the purification of His-tagged protein.

 

According to PhyNexus, the Qiagen resin will be used in its PhyTip columns, which are specifically designed for micro volume protein purification and enrichment. Additional terms of the deal were not disclosed.

 

Breaking News
The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.